RS1
Retinoschisin
Also known as: RS, XLRS1, XLRS1_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- O15537
- Gene
- RS1
- Ensembl
- ENSG00000102104
- Chromosome
- X
- Canonical length
- 224 aa
- Protein class
- Disease related genes, Human disease related genes, Potential drug targets, Predicted secreted proteins, Transporters
- Secretome location
- Secreted in other tissues
- Quaternary structure
- Homooctamer
OverviewNCBI Gene
This gene encodes an extracellular protein that plays a crucial role in the cellular organization of the retina. The encoded protein is assembled and secreted from photoreceptors and bipolar cells as a homo-oligomeric protein complex. Mutations in this gene are responsible for X-linked retinoschisis, a common, early-onset macular degeneration in males that results in a splitting of the inner layers of the retina and severe loss in vision. [provided by RefSeq, Oct 2008]
Canonical amino-acid sequenceUniProt
224 residues, UniProt reviewed canonical sequence.
>O15537|RS1
1 MSRKIEGFLL LLLFGYEATL GLSSTEDEGE DPWYQKACKC DCQGGPNALW SAGATSLDCI
61 PECPYHKPLG FESGEVTPDQ ITCSNPEQYV GWYSSWTANK ARLNSQGFGC AWLSKFQDSS
121 QWLQIDLKEI KVISGILTQG RCDIDEWMTK YSVQYRTDER LNWIYYKDQT GNNRVFYGNS
181 DRTSTVQNLL RPPIISRFIR LIPLGWHVRI AIRMELLECV SKCALocalizationUniProt · AlphaFold · HPA
Whether an antibody against RS1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.37
- Highest tissue expression
- 198 nTPM
Expression across tissuesHPA
Tissue
- retina: 198 nTPM
- lung: 0.9 nTPM
- cerebral cortex: 0.6 nTPM
- basal ganglia: 0.5 nTPM
- cerebellum: 0.2 nTPM
- amygdala: 0.1 nTPM
Single-cell type
- cone photoreceptor cells: 340 nCPM
- rod photoreceptor cells: 248 nCPM
- alveolar cells type 1: 24 nCPM
- syncytiotrophoblasts: 10 nCPM
- retinal horizontal cells: 6 nCPM
- müller glia: 5.1 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- cerebral cortex: 0.7 nTPM
- basal ganglia: 0.6 nTPM
- white matter: 0.3 nTPM
- amygdala: 0.2 nTPM
- cerebellum: 0.2 nTPM
- hippocampal formation: 0.2 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about RS1.
Disease | AllUniProt
Conditions RS1 is implicated in, by any mechanism.
- Retinoschisis juvenile X-linked 1 (XLRS1) MIM:312700
Disease | GeneticClinVar
288 pathogenic / likely-pathogenic of 649 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Juvenile retinoschisis
- Retinal dystrophy
- Retinoschisis
- Thyroid cancer, nonmedullary, 1
- Retinal disorder
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.3
- gnomAD pLI
- 0.96
- gnomAD missense Z
- 0.97
- DepMap mean gene effect
- 0.19
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
- phosphatidylinositol-3,4-bisphosphate binding
- phosphatidylserine binding
- protein-containing complex binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads RS1 as an antibody target. Whether an autoantibody or antibody against RS1 could matter depends on whether native RS1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
RS1 is annotated at the cell surface, where native RS1 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label RS1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...